Comparison of growth patterns in healthy dogs and dogs in abnormal body condition using growth standards
- PMID: 32966286
- PMCID: PMC7510995
- DOI: 10.1371/journal.pone.0238521
Comparison of growth patterns in healthy dogs and dogs in abnormal body condition using growth standards
Abstract
In dogs, optimal growth is critical for future health and wellbeing. Recently, a series of evidence-based growth standards, based on bodyweight, were developed for male and female dogs across 5 different size categories. The aim of the current study was to compare growth curves depicted by the standards with patterns of growth in dogs that were either healthy, had abnormal body condition, or had various diseases with the potential to affect growth. The data came from 2 research colonies in Europe (France and UK), and a large corporate network of primary care veterinary hospitals across the USA. Age and bodyweight data were used to model growth in healthy dogs, in dogs that became overweight or underweight by 3 years of age, and in dogs with diseases associated with altered growth. Centile line crossing during the growth phase was uncommon in healthy dogs, with <5% of dogs crossing >2 centile lines. In contrast, centile line crossing was more frequent in dogs with abnormal growth patterns or abnormal body condition. Dogs that developed obesity by 3 years grew faster than the growth standards predicted, and 68% crossed ≥2 centile lines in an upwards direction. Dogs with conditions associated with accelerated growth also grew faster than expected, and 54% crossed ≥2 centile lines. In contrast dogs that became underweight by 3 years gained weight slower than expected, and 49% crossed ≥2 centile lines in a downwards direction. These results suggest that the growth standards are useful for monitoring healthy growth in dogs. Prospective studies are now required to confirm these findings and to determine whether early intervention can prevent the development of diseases.
Conflict of interest statement
CS, PJM, and RFB are employees of WALTHAM, EML is an employee of Banfield Pet Hospitals, and both are owned by Mars Inc. AJG is an employee of the University of Liverpool, but his post is financially supported by Royal Canin, which is owned by Mars Petcare. AJG has also received financial remuneration for providing educational material, speaking at conferences, and consultancy work from this company; all such remuneration has been for projects unrelated to the work reported in this manuscript. TJC received financial remuneration for initial guidance on curve development, and for advice on developing charts as a clinical tool for growth monitoring. Remuneration was not received for drafting, reviewing and approving the manuscript for publication. None of these declarations alter our adherence to PLOS ONE policies on sharing data and materials.
Figures
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
